![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0015.png)
Prader-Willi syndroom
13
1.
Angulo M, Butler MG, Cataletto, ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J. Endocrinol
Invest. 2015. 38: 1249-1263.
2.
Bakker NE, Kuppens RJ, Siemensma EPC, Tummers-de Lind vanWijngaarden RFA, Festen DAM, Bindels-de Heus GCB et al. Eight
years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. J Clin Endocrinol
Metab. 2013 (Okt), 98 (10): 4013-4022.
3.
Bakker NE, Kuppens RJ, Siemensma EPC, Tummers-de Lind vanWijngaarden RFA, Festen DAM, Bindels-de Heus GCB et al. Bone
mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of
growth hormone treatment. J Clin Endocrinol Metab. 2015 (Apr). 100(4):1609-18.
4.
Bakker NE, Wolffenbuttel KP, Looijenga LHJ, Hokken-Koelega ACS. Testes in infants with Prader-Willi syndrome: human chorionic
gonadotropin treatment, surgery and histology. J Urol. 2015 (Jan). 193: 291-298.
5.
Buiting C, Njoo K. Richtlijn informatie uitwisseling tussen Huisarts en Specialist bij verwijzing (HASP). 2008. Nederlands
Huisartsen Genootschap.
www.nhg.org/themas/artikelen/richtlijn-informatie-uitwisseling-tussen-huisarts-en-specialist-bij- verwijzingen .6.
Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. Prevalence of, and risk factors for, physical ill-health in people with
Prader Willi syndrome; a population based study. Dev Med Child Neurol. 2002. 44: 248-255.
7.
De Lind vanWijngaarden RFA, De Klerk LWL, Festen DAM, Hokken-Koelega ACS. Scoliosis in Prader-Willi syndrome: prevalence,
effects of age, gender, body mass index, lean body mass and genotype. Arch Dis Child. 2008; 93: 1012-1016.
8.
De Lind vanWijngaarden RFA, Otten BJ, Festen DAM, Joosten KFM, De Jong FH, Sweep FCGJ et al. High prevalence of central
adrenal insufficiency in patients with Prader-Willi Syndrome. J Clin Endocrinol Metab, (May) 2008, 93(5):1649–1654.
9.
De Lind vanWijngaarden RFA, Siemensma EPC, Festen DAM, Otten BJ, Van Mil EGAH, Rotteveel J et al. Efficacy and safety of long-
term continuous growth hormone treatment in children with Prader-Willi syndrome. J Clin Endocrinol Metab. (November) 2009,
94(11):4205-4215.
10. Driscoll DJ, Miller JL, Schwarz S, Cassidy SB. Prader-Willi Syndrome. Gene Reviews. Pagon RA, AdamMP, Ardinger HH, et al. Seattle
(WA): University of Washington, Seattle. 2014.
11. Eijssens EC. Rapport ’Spierziekten als zeldzame ziekten in de huisartsenpraktijk’. 2006.
12. Elena G, Bruna C, Benedetta M, Stefania DC, Giuseppe C. Prader-Willi Syndrome; Clinical Aspects. Journal of Obesity. 2012. Doi:
10.1155/2012/473941.
13. Festen DAM, De Weerd, AW, Van den Bossche RAS, Joosten K, Hoeve H, Hokken-Koelega ACS. Sleep-Related Breathing Disorders
in Prepubertal Children with Prader-Willi Syndrome and Effects of Growth Hormone Treatment. J Clin Endocrinol Metab. 2006.
91(12):4911–4915.
14. Festen DAM, Wevers M, Lindgrent AC, Böhmt B, Otten BJ, Wit JM et al. Mental and motor development before and during growth
hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin. Endocrinol. 2008. 68, 919-925.
15. Hendriks SA. Generieke zorgthema Huisartsgeneeskundige zorg. 2014.
www.zorgstandaarden.net/nl/wat-is-een-zeldzame- aandoening/generieke-zorgthemas .16. Hokken-Koelega ACS, Otten BJ, Van Alfen-van der Velden AAEM, Festen DAM, Tummers-de Lind vanWijngaarden RFA, Siemensma.
Landelijke Richtlijn Diagnostiek en behandeling van kinderen met het Prader-Willi Syndroom. Nederlandse Vereniging voor
Kindergeneeskunde. 2013.
17. Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega ACS, Tauber M. Recommendations for the Diagnosis and Management of
Prader-Willi Syndrome. J Clin Endocrinol Metab. 2008 (nov). 93(11):4183–4197.
18. Lo ST, Siemensma E, Collin P, Hokken-Koelega A. Impaired theory of mind and symptoms of Autism SpectrumDisorder in children
with Prader-Willi syndrome. Res Dev Disabil. 2013 Sep;34(9):2764-73.
19. Lo ST, Siemensma E, Collin P, Hokken-Koelega A. Psychiatric disorders in children with Prader-Willi syndrome-result of a 2-year
longitudinal study. Am J Med Genet Part A. 2015. 167A: 983-991.
20. Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold JA, Kimonis V, et al. Nutritional phases in Prader-Willi Syndrome. Am J Med Genet
A. 2011 May; 155A (5): 1040-1049.
21. Orphanet Report Series. Prevalence and incidence of rare diseases: Bibliographic data. (Maart) 2016.
www.orpha.net/orphacom/ cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf .22. Reus L. Van Vlimmeren LA, Staal JB, Otten BJ, Nijhuis-van der Sanden MW. The effect of growth hormone treatment or physical
training on motor performance in Prader-Willi syndrome: a systematic review. Database of Abstracts of Reviews of Effects (DARE):
Quality-assessed Reviews. York (UK): Centre for Reviews and Dissemenation (UK) 2012.
Literatuurlijst